The serum fibroblast growth factor 21 is correlated with retinopathy in patients with type 2 diabetes mellitus
Authors:
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 15 (6) , 102296
Abstract
No abstract availableKeywords
Funding Information
- Zahedan University of Medical Sciences
This publication has 34 references indexed in Scilit:
- Vitreous and serum levels of vascular endothelial growth factor and platelet‐derived growth factor and their correlation in patients with non‐proliferative diabetic retinopathy and clinically significant macula oedemaActa Ophthalmologica, 2011
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant StateDiabetes, 2010
- Diabetic retinopathyThe Lancet, 2010
- Fibroblast Growth Factor-21 Is Induced in Human Skeletal Muscles by HyperinsulinemiaDiabetes, 2009
- Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese MiceDiabetes, 2009
- Adipose Fibroblast Growth Factor 21 Is Up-Regulated by Peroxisome Proliferator-Activated Receptor γ and Altered Metabolic StatesMolecular Pharmacology, 2008
- Circulating FGF-21 Levels in Normal Subjects and in Newly Diagnose Patients with Type 2 Diabetes MellitusExperimental and Clinical Endocrinology & Diabetes, 2007
- Molecular Insights into the Klotho-Dependent, Endocrine Mode of Action of Fibroblast Growth Factor 19 Subfamily MembersMolecular and Cellular Biology, 2007
- Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scalesOphthalmology, 2003
- Perspectives on diabetic retinopathyAmerican Journal of Ophthalmology, 2003